Annika Auranen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Annika Auranen has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Latchford
Polyposis Registry, St Mark's Hospital, Harrow, UK
1 shared publication - Anja Wagner
Department of Clinical Genetics, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands
1 shared publication - Anna Lepistö
Applied Tumor Genomics, Research Programs Unit, University of Helsinki, Helsinki, Finland
1 shared publication - Anne Goverde
Department of Clinical Genetics, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
1 shared publication - Anne Marie Jelsig
Department of Clinical Genetics, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
1 shared publication - Emma J. Crosbie
University of Manchester
1 shared publication
Latest Publications
- Open Access
- 27 January 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (3) , 473
The Management of Peutz–Jeghers Syndrome: European Hereditary Tumour Group (EHTG) Guideline
The scientific data to guide the management of Peutz–Jeghers syndrome (PJS) are sparse. The available evidence has been reviewed and discussed by diverse medical specialists in the field of PJS to update the previous guideline from 2010 and formulate a revised practical guideline for colleagues managing PJS patients. Methods: Literature searches were performed using MEDLINE, Embase, and Cochrane. Evidence levels and recommendation strengths were assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE). A Delphi process was followed, with consensus being reached when ≥80% of the voting guideline committee members agreed. Recommendations and statements: The only recent guidelines available were for gastrointestinal and pancreatic management. These were reviewed and endorsed after confirming that no more recent relevant papers had been published. Literature searches were performed for additional questions and yielded a variable number of relevant papers depending on the subject addressed. Additional recommendations and statements were formulated. Conclusions: A decade on, the evidence base for recommendations remains poor, and collaborative studies are required to provide better data about this rare condition. Within these restrictions, multisystem, clinical management recommendations for PJS have been formulated.
- 27 January 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (3) , 473
Open AccessThe Management of Peutz–Jeghers Syndrome: European Hereditary Tumour Group (EHTG) Guideline
The scientific data to guide the management of Peutz–Jeghers syndrome (PJS) are sparse. The available evidence has been reviewed and discussed by diverse medical specialists in the field of PJS to update the previous guideline from 2010 and formulate a revised practical guideline for colleagues managing PJS patients. Methods: Literature searches were performed using MEDLINE, Embase, and Cochrane. Evidence levels and recommendation strengths were assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE). A Delphi process was followed, with consensus being reached when ≥80% of the voting guideline committee members agreed. Recommendations and statements: The only recent guidelines available were for gastrointestinal and pancreatic management. These were reviewed and endorsed after confirming that no more recent relevant papers had been published. Literature searches were performed for additional questions and yielded a variable number of relevant papers depending on the subject addressed. Additional recommendations and statements were formulated. Conclusions: A decade on, the evidence base for recommendations remains poor, and collaborative studies are required to provide better data about this rare condition. Within these restrictions, multisystem, clinical management recommendations for PJS have been formulated.